During the past decade, Scien. Res. Institute of Obsterics, Gyn. & Reproduction conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Scien. Res. Institute of Obsterics, Gyn. & Reproduction" are "Leiomyoma" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Scien. Res. Institute of Obsterics, Gyn. & Reproduction" in a lesser frequency.

Most popular intervention types in "Scien. Res. Institute of Obsterics, Gyn. & Reproduction" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vilaprisan (BAY1002670)" (2 trials), "Placebo" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scien. Res. Institute of Obsterics, Gyn. & Reproduction" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Scien. Res. Institute of Obsterics, Gyn. & Reproduction". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Scien. Res. Institute of Obsterics, Gyn. & Reproduction, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Scien. Res. Institute of Obsterics, Gyn. & Reproduction, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".